Polymyxin B and rifampin: new regimen for multiresistant Serratia marcescens infections
- PMID: 201214
- PMCID: PMC429999
- DOI: 10.1128/AAC.12.6.655
Polymyxin B and rifampin: new regimen for multiresistant Serratia marcescens infections
Abstract
Polymyxin B and rifampin were given to 12 patients with multi-drug-resistant nosocomial Serratia marcescens infections. Eight cures were achieved; drug hepatotoxicity occurred once; one fatal suprainfection was encountered; and two patients died during therapy of causes related to severe underlying illnesses. Polymyxin B and rifampin were uniformly synergistic in vitro against the infecting strains and against 40 additional clinical isolates of S. marcescens.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
